U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday.
Harpoon Therapeutics, Inc. (HARP) rose sharply in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.
Harpoon Therapeutics shares jumped 98.6% to $20.95 in pre-market trading.
Here are some big stocks recording gains in today’s pre-market trading session.
- Heron Therapeutics, Inc. (HRTX) shares rose 14.1% to $2.02 in pre-market trading. Heron Therapeutics announced a five-year distribution partnership with CrossLink Life Sciences to expand promotional effort for ZYNRELEF.
- Better Home & Finance Holding Company (BETR) surged 11.2% to $0.7470 in pre-market trading.
- Sabre Corporation (SABR) climbed 5.1% to $4.57 in pre-market trading.
- Cronos Group Inc. (CRON) gained 4.1% to $2.27 in pre-market trading after gaining over 2% on Friday.
- Nextracker Inc. (NXT) climbed 4% to $43.65 in pre-market trading.
- Upwork Inc. (UPWK) rose 3.6% to $14.55 in pre-market trading.
- Altimmune, Inc. (ALT) gained 3.2% to $11.55 in pre-market trading after declining around 4% on Friday.
- Annexon, Inc. (ANNX) gained 3.2% to $4.78 in pre-market trading. Annexon outlined its 2024 priorities with late-stage clinical milestones across upstream complement portfolio for autoimmune, ophthalmic and neurodegenerative diseases.
Now Read This: How To Earn $500 A Month From Conagra Brands Stock Following Latest Earnings Report
Don’t forget to check out our premarket coverage here
